PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-02-18 (1)

Date Title Company
18-Feb-2023 Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, a New Once-Daily Formulation of AUSTEDO® (deutetrabenazine) Tablets Businesswire